Category Archives: Neurodiversity

‘Biased’ Channel 4 programme on ADHD misrepresented my views, says expert

Posted on by

Prof Katya Rubia withdraws support for The Great ADHD Myth? as other leading figures voice criticisms

A contributor to a controversial Channel 4 documentary on attention deficit hyperactivity disorder has withdrawn her support for the programme, saying it was biased and could lead to an increased suicide risk by encouraging parents to take their children off medication.

Katya Rubia, a professor of cognitive neuroscience at the Institute of Psychiatry, Psychology and Neuroscience at King’s College London, also said The Great ADHD Myth? misrepresented her views.

Continue reading...

‘Feels quite cruel’: Australians with ADHD scrambling to find medication amid shortage

Posted on by

Patient says pharmacists she went to were suspicious because Vyvanse is a stimulant, causing her the ‘most dehumanising medical experience’ of her life

Emma* says she was made to feel “like a drug addict” for simply trying to access medication for her ADHD.

When she was prescribed Vyvanse in June, she was relieved to realise she had found a treatment that would make it easier to live with the developmental disorder that affects the brain’s executive functioning.

Sign up for Guardian Australia’s free morning and afternoon email newsletters for your daily news roundup

Continue reading...

Record numbers in England taking ADHD medication, NHS data shows

Posted on by

Increase of 18% in a year attributed to more diagnoses, especially among younger women

A record number of people in England are taking medication used to treat ADHD, data shows, underlining a surge in the number of diagnoses.

Almost 278,000 patients in England were prescribed central nervous system stimulants (CNS) and drugs to treat attention deficit hyperactivity disorder (ADHD) between April 2023 and March 2024, latest NHS Business Services Authority data shows.

Continue reading...